Humacyte Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | 100.0% | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 5,632.9% | 5,971.2% | 1,607.4% | 10,644.4% | 1,003.2% | 2,111.3% | 6,384.2% | 9,180.8% | 880.3% | 1,126.2% | 6,603.2% | – | – | – | – | 31.3% | – | – | – | 50.0% | 382.8% | 688.7% | 282.2% | 2,327.6% | 411.7% | 303.2% | 766.8% | |
| -5,532.9% | -5,871.2% | -1,507.4% | -10,544.4% | -903.2% | -2,011.3% | -6,284.2% | -9,080.8% | -780.3% | -1,026.2% | -6,503.2% | – | – | – | – | -31.3% | – | – | – | 50.0% | -282.8% | -588.7% | -182.2% | -2,227.6% | -311.7% | -203.2% | -666.8% | |
| 5,632.9% | 5,971.2% | 1,607.4% | 10,644.4% | 9,765.8% | 2,111.3% | 6,384.2% | 9,180.8% | 7,001.7% | 1,126.2% | 55,925.8% | – | – | – | – | 187.0% | – | – | – | 285.8% | 2,982.2% | 7,311.0% | 2,293.9% | 3,127.4% | 3,931.7% | 4,469.0% | 3,276.0% | |
| 1,277.3% | 1,375.8% | 375.8% | 1,971.8% | 3,088.4% | 781.3% | 2,239.8% | 3,078.5% | 2,438.6% | 398.2% | 19,961.3% | – | – | – | – | 55.6% | – | – | – | 102.8% | 1,573.7% | 2,594.4% | 1,010.6% | 4,932.5% | 1,602.0% | 1,977.1% | 2,197.2% | |
| 1,277.3% | 1,375.8% | 375.8% | 2,094.4% | 11,851.0% | 781.3% | 2,239.8% | 3,137.9% | 8,560.1% | 398.2% | 69,283.9% | – | – | – | – | 211.3% | – | – | – | 438.6% | 4,201.5% | 9,287.4% | 3,056.8% | 4,375.4% | 5,533.7% | 6,446.1% | 4,574.0% | |
| -6,810.2% | -7,247.0% | -1,883.3% | -12,638.7% | -12,754.2% | -2,792.6% | -8,524.1% | -12,218.6% | -9,340.3% | -1,424.4% | -75,787.1% | – | – | – | – | -242.7% | – | – | – | -388.6% | -4,484.3% | -9,876.1% | -3,239.0% | -6,603.0% | -5,845.5% | -6,649.3% | -5,240.8% | |
| – | – | 60.1% | 436.3% | 343.9% | 176.1% | 499.6% | 788.7% | 614.6% | 114.4% | 5,293.5% | – | – | – | – | 16.0% | – | – | – | 34.7% | 580.3% | 845.5% | 346.9% | 662.3% | 458.8% | 571.7% | 485.5% | |
| -6,931.0% | -7,514.1% | -1,943.1% | -13,074.2% | -13,097.4% | -2,492.5% | -13,096.7% | 24,059.3% | -8,511.6% | 2,833.8% | -81,551.6% | – | – | – | – | -232.7% | – | – | – | -289.7% | 7,570.4% | -12,511.0% | -2,325.4% | -5,311.3% | -3,559.4% | -9,064.5% | -4,560.8% | |
| – | – | 1,938.6% | 12,919.9% | 0.6% | 176.1% | 3,198.8% | -38,184.2% | -1,443.3% | 114.4% | 471.0% | – | – | – | – | -260.0% | – | – | – | -24.2% | – | – | – | – | – | – | – | |
| -6,931.0% | -7,514.1% | -1,943.1% | -13,074.2% | -13,097.4% | -2,492.5% | -13,096.7% | 24,059.3% | -8,511.6% | 2,833.8% | -81,551.6% | – | – | – | – | -232.7% | – | – | – | -289.7% | 7,570.4% | -12,511.0% | -2,325.4% | -5,311.3% | -3,559.4% | -9,064.5% | -4,560.8% | |
| -5,985.9% | -6,191.4% | -1,655.5% | -10,963.7% | -11,750.3% | -2,017.0% | -11,742.7% | 26,004.0% | -7,016.7% | 3,103.5% | -69,654.8% | – | – | – | – | -185.4% | – | – | – | -230.0% | 8,505.0% | -11,047.5% | -1,730.8% | -4,266.2% | -2,739.0% | -8,163.5% | -3,755.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.